Walden Biosciences Revenue and Competitors

Boston, MA USA

Location

$51M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Walden Biosciences's estimated annual revenue is currently $2.5M per year.(i)
  • Walden Biosciences's estimated revenue per employee is $77,500
  • Walden Biosciences's total funding is $51M.

Employee Data

  • Walden Biosciences has 32 Employees.(i)
  • Walden Biosciences grew their employee count by -6% last year.

Walden Biosciences's People

NameTitleEmail/Phone
1
Head BioTherapeuticsReveal Email/Phone
2
Manager, Executive Office President & CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Walden Biosciences?

Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease. We are developing breakthrough medicines targeted directly to the kidney and will be successful through our comprehensive knowledge and understanding of novel kidney-specific biological pathways and our team's track record in drug discovery. Our goal is to transform the treatment of kidney disease by reversing its progression, enabling and inspiring patients to resume their normal lives. Our culture is collaborative and entrepreneurial, and our team is dynamic and driven by data and innovation. We want to make the best decisions with the best available information, lead by example, and bring transformative medicines to patients in need. Walden is based in the heart of Cambridge, MA between Harvard, Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital.

keywords:N/A

$51M

Total Funding

32

Number of Employees

$2.5M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Walden Biosciences News

2022-03-22 - Walden Biosciences Announces Presentation at the 32nd ...

Walden Biosciences Announces Presentation at the 32nd Annual Oppenheimer Healthcare Conference. March 11, 2022 07:00 ET | Source: Walden Biosciences,...

2022-03-22 - Walden Biosciences Announces Participation at 4th Annual ...

CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A32-9%N/A
#2
$3.5M3223%$85.2M
#3
$3.7M32N/AN/A
#4
$3.6M3219%N/A
#5
$6.9M3223%N/A